Ascletis Pharma ASCLF Stock
Ascletis Pharma Price Chart
Ascletis Pharma ASCLF Financial and Trading Overview
| Ascletis Pharma stock price | 1.32 USD |
| Previous Close | 1.67 USD |
| Open | 1.87 USD |
| Bid | 1.69 USD x 50000 |
| Ask | 1.98 USD x 30000 |
| Day's Range | 1.87 - 1.87 USD |
| 52 Week Range | 0.93 - 2.5 USD |
| Volume | 100 USD |
| Avg. Volume | 654 USD |
| Market Cap | 1.97B USD |
| Beta (5Y Monthly) | 0.474 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ASCLF Valuation Measures
| Enterprise Value | -242342880 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 973.1232 |
| Price/Book (mrq) | 6.5162325 |
| Enterprise Value/Revenue | -119.498 |
| Enterprise Value/EBITDA | 0.513 |
Trading Information
Ascletis Pharma Stock Price History
| Beta (5Y Monthly) | 0.474 |
| 52-Week Change | 79.08% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 2.5 USD |
| 52 Week Low | 0.93 USD |
| 50-Day Moving Average | 2 USD |
| 200-Day Moving Average | 1.75 USD |
ASCLF Share Statistics
| Avg. Volume (3 month) | 654 USD |
| Avg. Daily Volume (10-Days) | 833 USD |
| Shares Outstanding | 1.06B |
| Float | 218.82M |
| Short Ratio | N/A |
| % Held by Insiders | 65.17% |
| % Held by Institutions | 11.17% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -31063.56% |
| Gross Margin | 25.98% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.45% |
| Return on Equity (ttm) | -18.45% |
Income Statement
| Revenue (ttm) | 2.03M USD |
| Revenue Per Share (ttm) | 0.002 USD |
| Quarterly Revenue Growth (yoy) | -26.20% |
| Gross Profit (ttm) | 527K USD |
| EBITDA | -472385984 USD |
| Net Income Avi to Common (ttm) | -359880000 USD |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.9B USD |
| Total Cash Per Share (mrq) | 1.92 USD |
| Total Debt (mrq) | 5.16M USD |
| Total Debt/Equity (mrq) | 0.27 USD |
| Current Ratio (mrq) | 15.054 |
| Book Value Per Share (mrq) | 0.28697565 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -416776000 USD |
| Levered Free Cash Flow (ttm) | -300656000 USD |
Profile of Ascletis Pharma
| Country | United States |
| State | N/A |
| City | Wan Chai |
| Address | Dah Sing Financial Centre |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.ascletis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 202 |
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company's commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Further, it offers ASC30, for obesity; ASC47 for muscle-preserving weight loss treatment; and ASC39, a potent and amylin-selective oral small molecule amylin receptor agonist. Ascletis Pharma Inc. was founded in 2013 and is based in Wan Chai, Hong Kong.
Q&A For Ascletis Pharma Stock
What is a current ASCLF stock price?
Ascletis Pharma ASCLF stock price today per share is 1.32 USD.
How to purchase Ascletis Pharma stock?
You can buy ASCLF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ascletis Pharma?
The stock symbol or ticker of Ascletis Pharma is ASCLF.
Which industry does the Ascletis Pharma company belong to?
The Ascletis Pharma industry is Biotechnology.
How many shares does Ascletis Pharma have in circulation?
The max supply of Ascletis Pharma shares is 1.06B.
What is Ascletis Pharma Price to Earnings Ratio (PE Ratio)?
Ascletis Pharma PE Ratio is now.
What was Ascletis Pharma earnings per share over the trailing 12 months (TTM)?
Ascletis Pharma EPS is -0.05 USD over the trailing 12 months.
Which sector does the Ascletis Pharma company belong to?
The Ascletis Pharma sector is Healthcare.